TELA Bio
TELA
53 hedge funds and large institutions have $180M invested in TELA Bio in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
8% more funds holding
Funds holding: 49 → 53 (+4)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2.9% less ownership
Funds ownership: 90.97% → 88.07% (-2.9%)
10% less capital invested
Capital invested by funds: $200M → $180M (-$20.2M)
77% less call options, than puts
Call options by funds: $6K | Put options by funds: $26K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$597K |
| 2 |
Millennium Management
New York
|
+$554K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$545K |
| 4 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
+$408K |
| 5 |
Goldman Sachs
New York
|
+$388K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$4.49M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$1.64M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.33M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.03M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$845K |
TELA Hedge Fund Activity: Q1 2023 in Review
53 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2023, worth a combined $180M — down 10% from $200M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TELA positions and 4 closed out — a net gain of 4 holders — while 19 added to existing stakes and 15 trimmed.
The largest buyer was Silverarc Capital Management, opening a new position worth an estimated $597K. The largest seller was RTW Investments, exiting entirely with an estimated $4.49M sold.
- 53 institutional investors held TELA Bio (TELA) as of Q1 2023, up from 49 in Q4 2022.
- Funds reported $180M of TELA Bio stock for Q1 2023, down 10% quarter-over-quarter.
- 8 funds opened new TELA Bio positions in Q1 2023 and 4 closed out, a net change of +4 holders.
- The largest TELA Bio buyer in Q1 2023 was Silverarc Capital Management, an estimated $597K added.
- The largest TELA Bio seller in Q1 2023 was RTW Investments, an estimated $4.49M sold.
Based on aggregated 13F filings for Q1 2023.